Skip to content
An Oncology biotech pioneering RAD51 inhibition to treat high replication stress tumors
Linkedin
Home
Science
Team
Pipeline
News
Careers
Contact Us
X
Home
Science
Team
Pipeline
News
Careers
Contact Us
X
Satya @ JPM 2024
January 18, 2024
10:26 am
Satya had meetings with potential partners and collaborators to discuss its portfolio of programs during the JPM. A number of programs and collaboration ideas were discussed and would expand our agenda for 2024 and beyond.
Scroll to Top
